Legal Help and Information for Injury Victims
Home >> Gadolinium Contrast Dye Resources >> FDA WARNS ON VICKS NYQUIL, DAYQUIL MARKETING
Gadolinium Contrast Dye News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
FDA WARNS ON VICKS NYQUIL, DAYQUIL MARKETING
November 3, 2009
Early last month, the U.S. Food and Drug Administration (FDA) issued a warning to the Procter & Gamble Company regarding how the drug maker marketed some of its Vick’s brand cold medications. The letter was immediately retracted, with the FDA saying there was a computer problem that inappropriately released the letter. Now, reports the Associated Press [...]Related Gadolinium Contrast Dye Stories:
- Third Rituxan Patient Diagnosed with PML..
- Cruise Ship Norovirus Study Points Finger at Dirty Public Bathrooms..
- Chinese Drywall Repair Fraud Prompts Call for Crackdown..
Additional Injury and Gadolinium Contrast Dye Resources:
Complete the Form Below and Talk to Experienced Lawyers
